Table 1.
Analysis of M13 average titer (upper vs. lower tertile) as a CoR and a controlled risk CoP: CYD14 and CYD15 dengue VE trials
Marginalized risk ratio
|
Controlled risk ratio
|
e(0,1)
|
||||
|---|---|---|---|---|---|---|
| Trial | Point Est. | 95 CI |
Point Est. | 95 CI |
Point Est. | 95 CI UL |
| CYD14 | 0.17 | 0.08–0.29 | 0.38 | 0.18–0.66 | 11.6 | 6.3 |
| CYD15 | 0.05 | 0.02–0.09 | 0.10 | 0.04–0.20 | 43.7 | 22.0 |
Conservative (upper bound) estimate assuming unmeasured confounding at level
and thus
.
E-values are computed for upper tertile
vs. lower tertile
biomarker subgroups after controlling for age, sex, and country; UL = upper limit of 95
confidence interval.





